Effects of Vaccine Program against Pandemic Influenza A(H1N1) Virus, United States, 2009–2010
Open Access
- 1 March 2013
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 19 (3) , 439-48
- https://doi.org/10.3201/eid1903.120394
Abstract
In April 2009, the United States began a response to the emergence of a pandemic influenza virus strain: A(H1N1)pdm09. Vaccination began in October 2009. By using US surveillance data (April 12, 2009–April 10, 2010) and vaccine coverage estimates (October 3, 2009–April 18, 2010), we estimated that the A(H1N1)pdm09 virus vaccination program prevented 700,000–1,500,000 clinical cases, 4,000–10,000 hospitalizations, and 200–500 deaths. We found that the national health effects were greatly influenced by the timing of vaccine administration and the effectiveness of the vaccine. We estimated that recommendations for priority vaccination of targeted priority groups were not inferior to other vaccination prioritization strategies. These results emphasize the need for relevant surveillance data to facilitate a rapid evaluation of vaccine recommendations and effects.Keywords
This publication has 27 references indexed in Scilit:
- Post-Pandemic Seroprevalence of Pandemic Influenza A (H1N1) 2009 Infection (Swine Flu) among Children <18 Years in GermanyPLOS ONE, 2011
- H1N1 Hemagglutinin-Inhibition Seroprevalence in Emergency Department Health Care Workers After the First Wave of the 2009 Influenza PandemicPediatric Emergency Care, 2011
- Serologically Confirmed Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus During the First Pandemic Wave--New York City, April-May 2009Clinical Infectious Diseases, 2011
- Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. PopulationsJournal of Clinical Microbiology, 2011
- Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control StudyPLoS Medicine, 2011
- Safety and Effectiveness of a 2009 H1N1 Vaccine in BeijingNew England Journal of Medicine, 2010
- Estimates of the Prevalence of Pandemic (H1N1) 2009, United States, April–July 2009Emerging Infectious Diseases, 2009
- Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009New England Journal of Medicine, 2009
- Comparative Efficacy of Inactivated and Live Attenuated Influenza VaccinesNew England Journal of Medicine, 2009
- Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge StudiesAmerican Journal of Epidemiology, 2008